High Tower Advisors, LLC Novo Nordisk A S Transaction History

High Tower Advisors, LLC

  • $68.3 Billion
  • Q3 2024

A detailed history of High Tower Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, High Tower Advisors, LLC holds 479,773 shares of NVO stock, worth $50.4 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
479,773
Previous 510,365 5.99%
Holding current value
$50.4 Million
Previous $72.8 Million 21.58%
% of portfolio
0.08%
Previous 0.11%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$119.07 - $145.42 $3.64 Million - $4.45 Million
-30,592 Reduced 5.99%
479,773 $57.1 Million
Q2 2024

Aug 13, 2024
BUY
$122.71 - $146.91 $3.89 Million - $4.66 Million
31,697 Added 6.62%
510,365 $72.8 Million
Q1 2024

May 06, 2024
SELL
$102.11 - $135.92 $985,872 - $1.31 Million
-9,655 Reduced 1.98%
478,668 $61.5 Million
Q4 2023

Feb 12, 2024
BUY
$87.78 - $105.45 $4.4 Million - $5.29 Million
50,144 Added 11.44%
488,323 $50.5 Million
Q3 2023

Nov 08, 2023
BUY
$90.94 - $199.54 $22.3 Million - $49 Million
245,709 Added 127.66%
438,179 $39.8 Million
Q2 2023

Aug 14, 2023
BUY
$155.98 - $172.65 $4.14 Million - $4.58 Million
26,536 Added 15.99%
192,470 $31.1 Million
Q1 2023

May 11, 2023
SELL
$132.34 - $159.14 $772,865 - $929,377
-5,840 Reduced 3.4%
165,934 $26.4 Million
Q4 2022

Feb 08, 2023
BUY
$102.55 - $135.33 $901,209 - $1.19 Million
8,788 Added 5.39%
171,774 $23.2 Million
Q3 2022

Nov 09, 2022
BUY
$95.28 - $116.93 $3.59 Million - $4.4 Million
37,665 Added 30.05%
162,986 $16.2 Million
Q2 2022

Aug 10, 2022
BUY
$103.24 - $121.81 $1.12 Million - $1.32 Million
10,861 Added 9.49%
125,321 $14 Million
Q1 2022

May 12, 2022
BUY
$93.1 - $112.54 $2.21 Million - $2.68 Million
23,771 Added 26.21%
114,460 $12.7 Million
Q4 2021

Feb 10, 2022
SELL
$95.88 - $117.08 $2.29 Million - $2.8 Million
-23,904 Reduced 20.86%
90,689 $10.2 Million
Q3 2021

Nov 12, 2021
BUY
$84.42 - $106.62 $179,645 - $226,887
2,128 Added 1.89%
114,593 $11 Million
Q2 2021

Aug 06, 2021
BUY
$67.66 - $84.76 $433,971 - $543,650
6,414 Added 6.05%
112,465 $9.42 Million
Q1 2021

May 10, 2021
BUY
$67.06 - $75.82 $825,642 - $933,495
12,312 Added 13.13%
106,051 $7.13 Million
Q4 2020

Feb 10, 2021
BUY
$63.89 - $73.8 $1.24 Million - $1.43 Million
19,439 Added 26.16%
93,739 $6.53 Million
Q3 2020

Nov 13, 2020
BUY
$63.69 - $70.22 $224,953 - $248,017
3,532 Added 4.99%
74,300 $5.15 Million
Q2 2020

Aug 10, 2020
SELL
$58.54 - $67.94 $400,120 - $464,369
-6,835 Reduced 8.81%
70,768 $4.64 Million
Q1 2020

May 21, 2020
BUY
$49.46 - $64.78 $187,403 - $245,451
3,789 Added 5.13%
77,603 $4.66 Million
Q4 2019

Feb 14, 2020
SELL
$49.86 - $58.26 $43,926 - $51,327
-881 Reduced 1.18%
73,814 $4.28 Million
Q3 2019

Nov 12, 2019
BUY
$47.54 - $53.43 $294,462 - $330,945
6,194 Added 9.04%
74,695 $3.89 Million
Q2 2019

Aug 13, 2019
SELL
$46.79 - $52.47 $882,646 - $989,794
-18,864 Reduced 21.59%
68,501 $3.54 Million
Q1 2019

May 15, 2019
SELL
$46.36 - $52.63 $787,146 - $893,604
-16,979 Reduced 16.27%
87,365 $4.59 Million
Q4 2018

Feb 14, 2019
SELL
$41.54 - $47.25 $41,789 - $47,533
-1,006 Reduced 0.95%
104,344 $4.8 Million
Q3 2018

Nov 09, 2018
SELL
$46.76 - $51.24 $845,888 - $926,931
-18,090 Reduced 14.65%
105,350 $4.94 Million
Q2 2018

Aug 14, 2018
BUY
$44.29 - $50.42 $580,420 - $660,754
13,105 Added 11.88%
123,440 $5.71 Million
Q1 2018

May 15, 2018
SELL
$48.49 - $58.14 $1.01 Million - $1.21 Million
-20,892 Reduced 15.92%
110,335 $5.43 Million
Q4 2017

Feb 14, 2018
SELL
$47.53 - $53.73 $315,884 - $357,089
-6,646 Reduced 4.82%
131,227 $7.04 Million
Q3 2017

Nov 14, 2017
BUY
$41.15 - $49.22 $555,854 - $664,863
13,508 Added 10.86%
137,873 $6.64 Million
Q2 2017

Aug 14, 2017
BUY
N/A
124,365
124,365 $5.35 Million

Others Institutions Holding NVO

# of Institutions
1,954
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email